121 related articles for article (PubMed ID: 9849854)
1. Comparison of CD44 expression in early colorectal carcinomas of the de novo and ex adenoma types.
Mueller JD; Heider KH; Oberhuber G; Mueller E; Bethke B; Stolte M; Höfler H
Virchows Arch; 1998 Nov; 433(5):407-14. PubMed ID: 9849854
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of E-cadherin and stromelysin-3 expression in de novo and ex adenoma carcinoma of the colorectum.
Wlodarczyk J; Bethke B; Mueller E; Stolte M; Mueller J
Virchows Arch; 2001 Dec; 439(6):756-61. PubMed ID: 11787847
[TBL] [Abstract][Full Text] [Related]
3. Relation between stage, grade, proliferation, and expression of p53 and CD44 in adenomas and carcinomas of the colorectum.
Jackson PA; Green MA; Pouli A; Hubbard R; Marks CG; Cook MG
J Clin Pathol; 1995 Dec; 48(12):1098-101. PubMed ID: 8567994
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin, beta-catenin and stromelysin-3 expression in de novo carcinoma of the colorectum.
Włodarczyk J; Stolte M; Mueller J
Pol J Pathol; 2001; 52(3):119-24. PubMed ID: 11769398
[TBL] [Abstract][Full Text] [Related]
5. [Cyclo-oxygenase-2 and p53 immunoreactivity in superficial early colorectal carcinoma].
Kim YS; Lim SD; Lee JK; Kim SE; Ryu SH; Lee JW; Moon JS
Korean J Gastroenterol; 2006 May; 47(5):350-6. PubMed ID: 16714876
[TBL] [Abstract][Full Text] [Related]
6. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
[TBL] [Abstract][Full Text] [Related]
7. [Are there differences between ex adenoma and de novo colorectal carcinomas?].
Mueller J; Mueller E; Keller G; Bethke B; Stolte M; Höfler H
Verh Dtsch Ges Pathol; 1999; 83():139-47. PubMed ID: 10714204
[TBL] [Abstract][Full Text] [Related]
8. Expression of bcl-2 and p53 in de novo and ex-adenoma colon carcinoma: a comparative immunohistochemical study.
Mueller J; Mueller E; Hoepner I; Jütting J; Bethke B; Stolte M; Höfler H
J Pathol; 1996 Nov; 180(3):259-65. PubMed ID: 8958802
[TBL] [Abstract][Full Text] [Related]
9. CD44 and variants in melanocytic skin neoplasms.
Schaider H; Soyer HP; Heider KH; Hofmann-Wellenhof R; Zatloukal K; Smolle J; Kerl H
J Cutan Pathol; 1998 Apr; 25(4):199-203. PubMed ID: 9609138
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of CD44v6 in colorectal carcinomas is associated with hypermethylation of the CD44 promoter region.
Stallmach A; Wittig BM; Kremp K; Goebel R; Santourlidis S; Zeitz M; Menges M; Raedle J; Zeuzem S; Schulz WA
Exp Mol Pathol; 2003 Jun; 74(3):262-6. PubMed ID: 12782013
[TBL] [Abstract][Full Text] [Related]
11. p53 expression patterns in colorectal adenomas and early carcinomas: a special reference to depressed adenoma and non-polypoid carcinoma.
Yao T; Utsunomiya T; Nagai E; Oya M; Tsuneyoshi M
Pathol Int; 1996 Dec; 46(12):962-7. PubMed ID: 9110348
[TBL] [Abstract][Full Text] [Related]
12. Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types.
Blank M; Klussmann E; Krüger-Krasagakes S; Schmitt-Gräff A; Stolte M; Bornhoeft G; Stein H; Xing PX; McKenzie IF; Verstijnen CP
Int J Cancer; 1994 Nov; 59(3):301-6. PubMed ID: 7927933
[TBL] [Abstract][Full Text] [Related]
13. CD44V6 expression in human colorectal carcinoma.
Coppola D; Hyacinthe M; Fu L; Cantor AB; Karl R; Marcet J; Cooper DL; Nicosia SV; Cooper HS
Hum Pathol; 1998 Jun; 29(6):627-35. PubMed ID: 9635685
[TBL] [Abstract][Full Text] [Related]
14. Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis.
Mulder JW; Wielenga VJ; Polak MM; van den Berg FM; Adolf GR; Herrlich P; Pals ST; Offerhaus GJ
Gut; 1995 Jan; 36(1):76-80. PubMed ID: 7534253
[TBL] [Abstract][Full Text] [Related]
15. Expression of growth factors and their receptors in human early colorectal carcinomas: immunohistochemical study.
Shirai H; Ueno E; Osaki M; Tatebe S; Ito H; Kaibara N
Anticancer Res; 1995; 15(6B):2889-94. PubMed ID: 8669884
[TBL] [Abstract][Full Text] [Related]
16. [De novo cancer and adenoma-carcinoma sequence of the colorectum--clinicopathological differences between de novo carcinoma and carcinoma with the sequence].
Nakamura K
Nihon Geka Gakkai Zasshi; 1999 Dec; 100(12):766-75. PubMed ID: 10666721
[TBL] [Abstract][Full Text] [Related]
17. CD44 expression in benign and malignant colorectal polyps.
Neumayer R; Rosen HR; Reiner A; Sebesta C; Schmid A; Tüchler H; Schiessel R
Dis Colon Rectum; 1999 Jan; 42(1):50-5. PubMed ID: 10211520
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of CD44 splicing variants in advanced colorectal carcinomas.
Weg-Remers S; Anders M; von Lampe B; Riecken EO; Schüder G; Feifel G; Zeitz M; Stallmach A
Eur J Cancer; 1998 Sep; 34(10):1607-11. PubMed ID: 9893637
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity and microsatellite instability in de novo versus ex-adenoma carcinomas of the colorectum.
Mueller JD; Haegle N; Keller G; Mueller E; Saretzky G; Bethke B; Stolte M; Höfler H
Am J Pathol; 1998 Dec; 153(6):1977-84. PubMed ID: 9846987
[TBL] [Abstract][Full Text] [Related]
20. [Expression of proliferation and apoptosis related genes in colorectal adenoma with malignant transformation].
Wang H; Yao H; Ding W; Yan L; Yu X
Zhonghua Bing Li Xue Za Zhi; 2000 Dec; 29(6):405-8. PubMed ID: 11866939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
